These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 8913541)

  • 41. Losartan in patients with renal insufficiency.
    de Zeeuw D; Gansevoort RT; de Jong PE
    Can J Cardiol; 1995 Aug; 11 Suppl F():41F-44F. PubMed ID: 7664217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonpeptide angiotensin AT1 and AT2 receptor ligands modulate the upper limit of cerebral blood flow autoregulation in rats.
    Strömberg C; Näveri L; Saavedra JM
    J Cereb Blood Flow Metab; 1993 Mar; 13(2):298-303. PubMed ID: 8436622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of acute and chronic losartan therapy on active and inactive renin and active renin glycoforms.
    Opsahl JA; Goldberg MR; Katz SA
    Am J Hypertens; 1995 Nov; 8(11):1090-8. PubMed ID: 8554732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
    Goldberg MR; Lo MW; Christ DD; Chiou R; Furtek CI; Amit O; Carides A; Biollaz J; Piguet V; Nussberger J; Brunner HR
    Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiotensin receptors and their therapeutic implications.
    Griendling KK; Lassègue B; Alexander RW
    Annu Rev Pharmacol Toxicol; 1996; 36():281-306. PubMed ID: 8725391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin II receptor antagonism: losartan - sites and mechanisms of action.
    Triggle DJ
    Clin Ther; 1995; 17(6):1005-30. PubMed ID: 8750395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new antihypertensive class: the angiotensin receptor antagonist.
    Kupecz D
    Nurse Pract; 1996 Mar; 21(3):106, 109, 113-4. PubMed ID: 8710244
    [No Abstract]   [Full Text] [Related]  

  • 48. Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan.
    Hajj-Ali AF; Wong PC
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1423-7. PubMed ID: 7903389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of losartan, an AT1 selective angiotensin II receptor antagonist, on isoproterenol-induced cardiac ornithine decarboxylase activity.
    Nakano M; Kanda T; Matsuzaki S; Hasegawa S; Ma H; Imai S; Suzuki T; Kobayashi I
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):21-30. PubMed ID: 7620835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Therapy of arterial hypertension with angiotensin receptor blockers].
    Nobre FL
    Rev Port Cardiol; 1999 Apr; 18(4):407-12. PubMed ID: 10371849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiotensin receptors: physiology and pharmacology.
    Guthrie GP
    Clin Cardiol; 1995 Jun; 18(6 Suppl 3):III 29-34. PubMed ID: 7634561
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacodynamic, pharmacokinetic and clinical profile of the first orally active angiotensin II receptor antagonist.
    Reid JL
    Cardiologia; 1995 Dec; 40(12 Suppl 1):187. PubMed ID: 8903052
    [No Abstract]   [Full Text] [Related]  

  • 53. Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists.
    Owen RA; Molon-Noblot S; Hubert MF; Siegl PK; Eydelloth RS; Keenan KP
    Lab Invest; 1994 Oct; 71(4):543-51. PubMed ID: 7967510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The potential role of nitric oxide in angiotensin II-receptor blockade.
    Cachofeiro V; Maeso R; Muñoz-Garcia R; Lahera V
    Blood Press Suppl; 1996; 2():29-35. PubMed ID: 8913537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy.
    Eberhardt RT; Kevak RM; Kang PM; Frishman WH
    J Clin Pharmacol; 1993 Nov; 33(11):1023-38. PubMed ID: 8300885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin antagonists.
    Brunner HR; Nussberger J; Waeber B
    Adv Nephrol Necker Hosp; 1993; 22():305-27. PubMed ID: 8427061
    [No Abstract]   [Full Text] [Related]  

  • 57. ACE inhibitors, angiotensin II antagonists and cough. The Losartan Cough Study Group.
    Ramsay LE; Yeo WW
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S51-4. PubMed ID: 8583482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Non-peptide antagonists to angiotensin II receptors. A review].
    Schambye HT; Hjorth SA; Schwartz TW
    Ugeskr Laeger; 1993 Nov; 155(44):3558-62. PubMed ID: 8236577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
    Coca A; Giner V
    Rev Esp Cardiol; 1999; 52 Suppl 3():53-8. PubMed ID: 10614150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Losartan for hypertension.
    Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.